Pharvaris N.V. (PHVS) stock

PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Apr 2, 2026Score 4/30

$34.18+0.19 (+0.56%)

Close on Nov 11, 2026Market cap $2.23BP/E –Yield –

Pharvaris statistics

41 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: –

Valuation ratiosIndustry

Market Cap: €2.00B; €804.14M
Enterprise Value: €1.68B; €571.68M

Share statisticsIndustry

Shares Outstanding: 65M; 100M
Shares Change (YoY): 9.51%; 5.61%
Float: 64M; 79M
Shares Held by Insiders: 2.42%; 9.05%
Shares Held by Institutions: 99.2%; 20.8%

Short sellingIndustry

Short Interest: 3M; –
Short Interest Change: 3.01%; -2.55%
Days to Cover: 3.58; 3.54

Stock price statisticsIndustry

Price Change (1 Week): -0.44%; 2.02%
Price Change (1 Month): 13.9%; 8.16%
Price Change (3 Months): 0.41%; -13.7%
Price Change (6 Months): 3.76%; -4.97%
Price Change (YTD): 23.2%; -8.54%
Price Change (1 Year): 51.0%; -15.2%
Price Change (3 Years): 102.8%; -8.79%
Price Change (5 Years): 106.7%; -53.0%
Average Volume (10 Days): 702,448; –
Average Volume (20 Days): 671,003; –
Average Volume (90 Days): 711,786; –
Relative Volume: 0.59; 0.70
Relative Strength Index (14): 57.2; 55.5
Volatility (1 Year): 54.0%; 65.1%
Beta (5 Years): -0.53; 0.87

EfficiencyIndustry

Employee Count: 80,000; 304
WACC: 7.38%; 9.36%

Income statement (TTM)Industry

Operating Income: -€173.71M; -€54.01M
Pretax Income: -€173.71M; -€47.40M
EBITDA: -€173.71M; -€42.85M
EPS (Diluted): -2.97 EUR; -0.55 EUR

Balance sheetIndustry

Cash & Short-Term Investments: €318.28M; €199.29M
Net Cash (Debt): €318.28M; €111.50M
Net Cash Per Share: 4.88 EUR; 1.53 EUR

Cash flow (TTM)Industry

Operating Cash Flow: -€137.07M; -€42.16M
Capital Expenditures: -€164.62K; -€2.34M
Free Cash Flow: -€137.24M; -€52.90M
FCF Per Share: -2.10 EUR; -0.48 EUR

Dividends and yieldsIndustry

FCF Yield: -6.87%; -13.2%

Taxes and interestIndustry

Income Tax: €1.99M; €80.00K

Scores and fair valueIndustry

Altman Z-Score: 38.45; 1.20

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	PHVS	S&P 500	Difference	PHVS per year	S&P 500 per year
1 month	+9.9%	-2.4%	+12.3 pts
3 months	-0.7%	-1.2%	+0.5 pts
Year to date	+23.2%	+12.3%	+10.9 pts
1 year	+41.7%	+12.4%	+29.3 pts
3 years	+94.2%	+78.8%	+15.4 pts	+24.8%	+21.4%
5 years	+113.6%	+75.2%	+38.5 pts	+16.4%	+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M PHVS shares were sold short on Oct 30, 2026, up 3.0% from the previous report. At recent volumes it would take 3.6 days to buy them back. Over the last 20 sessions, 38.2% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	2,539,475	+3.0%	708,619	3.6
Oct 15, 2026	2,465,342	+22.8%	614,033	4.0
Sep 30, 2026	2,007,998	+12.5%	707,991	2.8
Sep 15, 2026	1,784,789	-17.4%	1,441,851	1.2
Aug 31, 2026	2,160,966	+21.7%	638,810	3.4
Aug 14, 2026	1,775,021	+48.7%	638,201	2.8
Jul 31, 2026	1,193,401	+5.0%	313,550	3.8
Jul 15, 2026	1,136,733	+15.3%	676,462	1.7
Jun 30, 2026	985,973	-12.0%	434,694	2.3
Jun 15, 2026	1,119,887	+58.0%	377,862	3.0
May 29, 2026	708,630	+18.0%	270,617	2.6
May 15, 2026	600,645	-42.9%	463,899	1.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?